Industry Growth Insights published a new data on “Radioimmunoassay Kits Market”. The research report is titled “Radioimmunoassay Kits Market research by Types (Pure Antigen, Radio Labelled Antigen, Antibody), By Applications (Infectious Disease Testing, Allergy Testing, Oncology Testing, Endocrine Testing, Toxicology Testing, Autoimmune Disease Testing, Others), By Players/Companies Beckman Coulter, DIAsource ImmunoAssays, DiaSorin, EMD Millipore, Berthold Technologies, Cisbio, IBL, Euro Diagnostica, Izotope, MP Biomedicals, PerkinElmer, Stratec Biomedical”.
Scope Of The Report
Report Attributes
Report Details
Report Title
Radioimmunoassay Kits Market Research Report
By Type
Pure Antigen, Radio Labelled Antigen, Antibody
By Application
Infectious Disease Testing, Allergy Testing, Oncology Testing, Endocrine Testing, Toxicology Testing, Autoimmune Disease Testing, Others
By Companies
Beckman Coulter, DIAsource ImmunoAssays, DiaSorin, EMD Millipore, Berthold Technologies, Cisbio, IBL, Euro Diagnostica, Izotope, MP Biomedicals, PerkinElmer, Stratec Biomedical
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
241
Number of Tables & Figures
169
Customization Available
Yes, the report can be customized as per your need.
Global Radioimmunoassay Kits Market Report Segments:
The global Radioimmunoassay Kits market is segmented on the basis of:
Types
Pure Antigen, Radio Labelled Antigen, Antibody
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Infectious Disease Testing, Allergy Testing, Oncology Testing, Endocrine Testing, Toxicology Testing, Autoimmune Disease Testing, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Beckman Coulter
- DIAsource ImmunoAssays
- DiaSorin
- EMD Millipore
- Berthold Technologies
- Cisbio
- IBL
- Euro Diagnostica
- Izotope
- MP Biomedicals
- PerkinElmer
- Stratec Biomedical
Highlights of The Radioimmunoassay Kits Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Pure Antigen
- Radio Labelled Antigen
- Antibody
- By Application:
- Infectious Disease Testing
- Allergy Testing
- Oncology Testing
- Endocrine Testing
- Toxicology Testing
- Autoimmune Disease Testing
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Radioimmunoassay Kits Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Radioimmunoassay kits are used to measure the levels of a specific protein in a sample.
Some of the major companies in the radioimmunoassay kits market are Beckman Coulter, DIAsource ImmunoAssays, DiaSorin, EMD Millipore, Berthold Technologies, Cisbio, IBL, Euro Diagnostica, Izotope, MP Biomedicals, PerkinElmer, Stratec Biomedical.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Radioimmunoassay Kits Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Radioimmunoassay Kits Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Radioimmunoassay Kits Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Radioimmunoassay Kits Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Radioimmunoassay Kits Market Size & Forecast, 2020-2028
4.5.1 Radioimmunoassay Kits Market Size and Y-o-Y Growth
4.5.2 Radioimmunoassay Kits Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Pure Antigen
5.2.2 Radio Labelled Antigen
5.2.3 Antibody
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Infectious Disease Testing
6.2.2 Allergy Testing
6.2.3 Oncology Testing
6.2.4 Endocrine Testing
6.2.5 Toxicology Testing
6.2.6 Autoimmune Disease Testing
6.2.7 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Radioimmunoassay Kits Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Radioimmunoassay Kits Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Pure Antigen
9.6.2 Radio Labelled Antigen
9.6.3 Antibody
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Infectious Disease Testing
9.10.2 Allergy Testing
9.10.3 Oncology Testing
9.10.4 Endocrine Testing
9.10.5 Toxicology Testing
9.10.6 Autoimmune Disease Testing
9.10.7 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Pure Antigen
10.6.2 Radio Labelled Antigen
10.6.3 Antibody
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Infectious Disease Testing
10.10.2 Allergy Testing
10.10.3 Oncology Testing
10.10.4 Endocrine Testing
10.10.5 Toxicology Testing
10.10.6 Autoimmune Disease Testing
10.10.7 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Pure Antigen
11.6.2 Radio Labelled Antigen
11.6.3 Antibody
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Infectious Disease Testing
11.10.2 Allergy Testing
11.10.3 Oncology Testing
11.10.4 Endocrine Testing
11.10.5 Toxicology Testing
11.10.6 Autoimmune Disease Testing
11.10.7 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Pure Antigen
12.6.2 Radio Labelled Antigen
12.6.3 Antibody
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Infectious Disease Testing
12.10.2 Allergy Testing
12.10.3 Oncology Testing
12.10.4 Endocrine Testing
12.10.5 Toxicology Testing
12.10.6 Autoimmune Disease Testing
12.10.7 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Pure Antigen
13.6.2 Radio Labelled Antigen
13.6.3 Antibody
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Infectious Disease Testing
13.10.2 Allergy Testing
13.10.3 Oncology Testing
13.10.4 Endocrine Testing
13.10.5 Toxicology Testing
13.10.6 Autoimmune Disease Testing
13.10.7 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Radioimmunoassay Kits Market: Competitive Dashboard
14.2 Global Radioimmunoassay Kits Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Beckman Coulter
14.3.2 DIAsource ImmunoAssays
14.3.3 DiaSorin
14.3.4 EMD Millipore
14.3.5 Berthold Technologies
14.3.6 Cisbio
14.3.7 IBL
14.3.8 Euro Diagnostica
14.3.9 Izotope
14.3.10 MP Biomedicals
14.3.11 PerkinElmer
14.3.12 Stratec Biomedical
